(MedPage Today) — In a small phase II trial, radiation-free treatment with pembrolizumab (Keytruda) and platinum-based chemotherapy alone proved promising for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and…
Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/117925
Author :
Publish date : 2025-10-13 20:57:00
Copyright for syndicated content belongs to the linked Source.
